Conference Speakers

Confirmed Speakers
Nayanika Chatterjee

Nayanika Chatterjee

Research, MarketsandMarkets

Nayanika Chatterjee dons multiple hats in her roles as an analyst with the healthcare consulting team as well as the SME for Genomics at MarketsandMarkets. She brings a comprehensive experience in market research and consulting across healthcare and life science domains, with focus on pharmaceuticals and biotechnology. Having worked with esteemed clients across the genomics board – such as, Thermo Fisher Scientific, MilliporeSigma, and QIAGEN, she is passionate about creating a tangible revenue impact for her clients by helping them devise effective and actionable growth strategies.

Dr. Anthony Marotta

Dr. Anthony Marotta

Medical Director, Amoy Diagnostics

Dr. Anthony Marotta, Ph.D. is the North American Medical Director for Amoy Diagnostics (AmoyDx), Canada. In this position, Marotta supports AmoyDx with overseeing key opinion leader engagement and establishing/overseeing investigator initiated activities. Marotta has been in the IVD industry since 2008 where he worked as the Chief Scientific Officer at Augurex Life Sciences Corp. During Marotta's eleven year tenure at Augurex he was responsible for the development of the 14-3-3η biomarker programs and the successful approvals of the JOINTstat™ blood test in Canada, Europe, Australia and the United States. During his time at Augurex, Marotta co-published 90 conference proceedings and 10 peer reviewed publications with key opinion leaders citing the clinical benefits of measuring the JOINTstat™ marker along the continuum of disease. Marottta is also an Adjunct Professor in the Division of Rheumatology, Faculty of Medicine at the University of British Columbia. Marotta began his scientific career in research at Kinetek Pharmaceuticals whilst pursuing his Ph.D. in Experimental Medicine at the University of British Columbia. Marotta’s Ph.D.centered on investigating the role of Integrin Linked Kinase in the development of sporadic colon cancer and the hereditary familial adenomatous (FAP) form of the disease. 

Jun Yin

Jun Yin

Associate Director, Bioinformatics, Ferring Pharmaceuticals

Dr. Jun Yin is the Associate Director of Bioinformatics at Ferring Pharmaceuticals, the world leader in reproductive medicine and maternal health. Dr. Jun Yin has more than 15 years of experience in Bioinformatics research, specializing in NGS data analysis, algorithm and pipeline development, and data mining and management. Dr. Yin has supported drug development pipelines for different therapeutic areas for target discovery and validation, MOA, biomarkers, and toxicogenomics studies. His work contributed to several FDA approved drugs and supported many IND filings. He was previously the Director of Bioinformatics Core for the premier NCI designated Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, Senior Scientist and team lead at Amgen, and received postdoctoral training at Yale University. Dr. Yin has published more than 30 scientific articles in the preeminent peer-reviewed journals, including Science, Cell, and Nature magazine.

Amit Shah

Amit Shah

VP -Client Partner, Sales, MarketsandMarkets

Amit has always had an approach of delivering customer-centric technology solutions. He has a knack for understanding customer challenges, their inherent causes, and is able to leverage his knowledge of advance technologies and capabilities to deliver custom solutions to bring much-desired business outcomes to his customers. This approach has served him well over the years, as he has been instrumental in securing several high-profile accounts.

At Current role, Amit is responsible for Revenue Growth, driving business outcome for new clients by tapping latent opportunities in respective and adjacent industries, enabling sales team to adopt a consultative and unified sales process and expand MarketsandMarkets footprint in North America , EMEA and APAC region for Healthcare domains. With c-level experience in managing worldwide sales team, driving sales growth into new market with management consulting capabilities, Amit has successfully demonstrated his business acumen and expertise in the US healthcare domain by handling multi-million accounts and delivering consistent revenue growth.

In pervious roles, Amit has been instrumental in expanding the company’s footprint across the European and APAC region. He has brought many marquee net new customers with multi-million dollar deals. He was responsible for creating a market opportunity worth a billion dollars - “iReward” - for the P&C Industry by leveraging Big Data technologies.

Amit holds an MS in Computer Science from Pune University. He also earned Software Engineering degree from Pace University.

Donald L. Davis

Donald L. Davis

President and Principal, 5280 Life Sciences Consulting, LLC

Don Davis PhD, MBA  is an expert operations leader in Healthcare and Life Sciences with a 30-year career in delivering leverageable capabilities that scale their organizations while increasing revenue and controlling cost.  His expertise in Diagnostics, NGS and Artificial Intelligence (AI) are often sought after by leaders in Life Sciences.  After decades of working for companies like GE, BD & Roche in the fields of Healthcare and Life Sciences, Don helps others improve Operational Excellence, Program & Project Management, Analytics & KPI’s and IT Systems & Infrastructure that result in increasing profitability and improved ability to scale their organizations for growth as President & Principal of 5280 Life Sciences Consulting.  Additionally, he is the host of a podcast titled Life Science Success (www.lifesciencesuccess.com) where he interviews Leaders in Life Sciences.

 

Connect with us
Top Market Reports | Conferences | Research Insight | Blog | New Reports
© 2021 MarketsandMarkets Research Private Ltd. All rights reserved
Subscribe Newsletter
By subscribing to our mailing list you will always get latest news from us.